Jump to content

Genedata Screener for Compound Profiling

Genedata Screener

Drug research strives for a full assessment of hit and lead compounds as early as possible in the discovery process. Thus, there is a need to conduct more complex experiments and to compare results from complementary or orthogonal assays and technologies. Genedata Screener® for Compound Profiling allows review of data sets consolidated from related assays together with systematic assessment of compound bioactivity and pharmacology across assays. The software helps identify promising molecules and structure classes from sets of assays, across technologies, focusing on biological relevance and ensuring that only the most promising compounds are selected for further studies.